aug 6, 2024 - EMA Orphan Drug Designation
Peripheral T-cell Lymphomas
SLS009
Description:
https://ir.sellaslifesciences.com/news/News-Details/2024/SELLAS-Receives-EMA-Orphan-Drug-Designation-for-SLS009-for-Treatment-of-Peripheral-T-cell-Lymphomas/default.aspx
Added to timeline:
Date:
~ 1 years and 10 months ago